ScoreWhy is Biocon Ltd. ?
1
Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.49 times
- Poor long term growth as Operating profit has grown by an annual rate 9.87% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.49 times
- The company has been able to generate a Return on Equity (avg) of 5.62% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Operating profit has grown by an annual rate 9.87% of over the last 5 years
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Biocon for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Biocon
18.35%
0.71
25.80%
Sensex
-4.33%
-0.32
13.49%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.83%
EBIT Growth (5y)
9.87%
EBIT to Interest (avg)
4.90
Debt to EBITDA (avg)
4.70
Net Debt to Equity (avg)
0.39
Sales to Capital Employed (avg)
0.43
Tax Ratio
17.66%
Dividend Payout Ratio
5.92%
Pledged Shares
0
Institutional Holding
31.59%
ROCE (avg)
5.98%
ROE (avg)
5.62%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
84
Industry P/E
34
Price to Book Value
1.86
EV to EBIT
50.52
EV to EBITDA
21.77
EV to Capital Employed
1.64
EV to Sales
4.42
PEG Ratio
NA
Dividend Yield
0.11%
ROCE (Latest)
3.25%
ROE (Latest)
2.21%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend18What is working for the Company
PAT(Latest six months)
Higher at Rs 627.61 cr
PBT LESS OI(Q)
At Rs 275.40 cr has Grown at 70.7% (vs previous 4Q average
DEBT-EQUITY RATIO(HY)
Lowest at 0.45 times
NET SALES(Q)
Highest at Rs 4,516.60 cr
-5What is not working for the Company
ROCE(HY)
Lowest at 3.69%
PAT(Q)
At Rs 190.41 cr has Fallen at -14.2% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is working for Biocon
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 275.40 cr has Grown at 70.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 161.30 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
Highest at Rs 4,516.60 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Debt-Equity Ratio - Half Yearly
Lowest at 0.45 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Biocon
Profit After Tax (PAT) - Quarterly
At Rs 190.41 cr has Fallen at -14.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 221.89 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
